India Patent Cases
2,823 decisions indexed
Page 81 of 95 · 2,823 total
S.M.Anand Vel v.Union of India
The petitioner challenged an order by the Assistant Controller of Patents & Designs which deemed his patent application abandoned because it was not put in order within the prescribed time. The petitioner argued that since multiple sets of fresh objections were raised during the examination process, the abandonment could not be applied. The Madras High Court set aside the impugned order and remanded the matter for a fresh consideration.
Reckitt Benckiser Health Care (India) Pvt. v.Emami Ltd & Ors.
The appeal challenged a temporary injunction granted by the Trial Court, which restrained the defendant from displaying an advertisement for 'MOOV' that compared it to the plaintiff's product, ZANDU BALM. The High Court examined whether such comparative advertising amounted to disparagement of the plaintiff's trademark and copyright.
Telefonaktiebolaget Lm Ericsson (Pub) v.Mercury Electronics & Anr
The dispute concerns the validity of several registered patents. The defendant challenged the validity of these patents in their counter-claim. The court addressed the legal issue of who must prove the patent's invalidity.
Indian Performing Rights Society Ltd. v.Sanjay Dalia & Anr.
This Supreme Court judgment addressed complex issues surrounding territorial jurisdiction in IP litigation, specifically interpreting Sections 62 of the Copyright Act and 134(2) of the Trade Marks Act. The core dispute centered on whether a plaintiff could file an infringement suit where they carried on business, even if the cause of action arose elsewhere. The Court ruled that while a plaintiff can sue where they operate, if the cause of action also arises at that location, they must file there.
Indian Performing Rights Society Ltd. v.Sanjay Dalia & Anr.
This Supreme Court judgment addressed complex issues surrounding territorial jurisdiction in IP litigation, specifically interpreting Sections 62 of the Copyright Act and 134(2) of the Trade Marks Act. The core dispute revolved around whether a plaintiff could file an infringement suit where they carried on business, even if the cause of action arose elsewhere. The Court clarified that while a plaintiff can sue where they operate, if the cause of action also arises at their location, they must file there.
Custom, Excise & Service Tax Tribunal v.M/S Brightpoint India Pvt. Ltd.
Revenue appealed an order regarding the recovery of demurrage and detention charges from a patent holder (Shri S. Ramkumar) who had executed a bond during customs clearance suspension due to alleged infringement by dual SIM mobile phones. The Tribunal dismissed the appeal, holding that the Commissioner (Appeals)' order was correct in allowing the enforcement of the bond for recovering these ancillary liabilities.
Bristol-Myers Squibb Company v.Mr.D. Shah
Bristol-Myers Squibb Company filed two suits seeking permanent injunctions and damages against Mr. D. Shah and others for infringing its Indian Patent No. 203937. The patent covers DASATINIB, an anti-cancer molecule used to treat chronic myeloid leukemia (CML). Given the defendants' admission of infringement and the risk of irreparable harm, the Delhi High Court allowed the injunction applications, maintaining the status quo during the trial.
Bristol-Myers Squibb Company v.Mr. J.D. Joshi
Bristol-Myers Squibb Company filed two suits seeking permanent injunction and damages against the defendants for infringing its Indian Patent No. 203937, which covers the anti-cancer drug DASATINIB. The plaintiffs argued that the defendants intended to launch generic products violating their exclusive patent rights. Given the prima facie evidence of infringement and the irreparable harm the plaintiff would suffer, the court granted an interim injunction to maintain the status quo during the trial.
Eicher Goodearth Pvt Ltd v.Krishna Mehta & Ors
Eicher Goodearth Pvt Ltd filed a suit seeking permanent injunction against Krishna Mehta & Ors, alleging that the defendants were illegally imitating and selling products featuring motifs and designs similar to those owned by Eicher Goodearth. The plaintiff claimed ownership of various designer collections like Serai and Falcon, asserting their rights under copyright and design laws. The court examined the similarity between the parties' products and the alleged deceptive use of intellectual property.
Jasper Motors Private Ltd. v.The Proprietor, Basantee Battery Operated Rickshaw & Ors.
The plaintiffs, holding a patent for an eco-friendly, battery-operated rickshaw design, alleged that the defendants were illegally importing, exporting, and selling the patented idea. Despite the lack of representation from the defendants, the court found them liable for infringing the patent.
United Phosphorus Limited v.Ajay Garg And Another
United Phosphorus Limited filed a suit seeking permanent injunction against infringement of Indian Patents Nos. 190476 and 202013, along with claims for damages. The defendants challenged the court's territorial jurisdiction, arguing that neither party conducted business in Delhi. The Court ultimately ruled that since no part of the cause of action arose within its jurisdiction, the plaint was returned to be filed in the appropriate forum.
M/s Best IT World (India) Private Limited v.M/s Telefonaktiebolaget L M Ericsson (Publ)
Best IT World (iBall) filed an information alleging that Ericsson, a major holder of Standard Essential Patents (SEPs), was abusing its dominant position. The allegations included refusal to identify infringed patents, forcing the Informant into onerous Non-Disclosure Agreements (NDAs), and imposing royalty rates contrary to FRAND terms.
Kanishk Sinha v.Union of India
Kanishk Sinha challenged the implementation of an amended notification under the Motor Vehicles Act, 1988, which brought 'E-rickshaws' within its ambit. The petitioner also claimed infringement of his patent related to technology for battery operated e-rickshaws.
The Delhi Network Of Positive People v.Union Of India
This Public Interest Litigation (PIL) challenged the practice of pharmaceutical companies abusing Section 16 of the Patents Act, 1970. The petitioner argued that filing identical divisional patent applications was used to keep patents alive and obstruct access to affordable medicines, particularly ARVs for HIV/AIDS patients. While acknowledging the merit in the grievance regarding process abuse, the court ultimately held that it could not issue directions requiring the Executive to amend statutory rules or interfere with the domain of administrative procedure, instead directing the respondents to consider rule amendments as a representation.
M/s.Kaleesuwari Refinery Pvt.Ltd v.M/s.Vignesh Refineries
M/s.Kaleesuwari Refinery Pvt.Ltd filed suit against M/s.Vignesh Refineries alleging infringement of its registered trademark (GOLD WINEER) and copyrighted pouch design. The dispute centered on the defendant's use of 'SKS GOLD' packaging, which was deemed infringing by the plaintiff. Both parties subsequently entered into a Memorandum of Compromise, amicably settling their differences.
Darius Rutton Kavasmaneck v.Gharda Chemicals Ltd.
This appeal involved a minority shareholder, Darius Rutton Kavasmaneck, challenging Gharda Chemicals Ltd. (Defendant No. 1) and its Managing Director (Defendant No. 2). The core grievance was that Defendant No. 2 had obtained several patents in his individual name despite using the company's substantial research and development infrastructure and investment. The plaintiff argued these patents belonged to the company, asserting a fiduciary duty breach by the MD. However, the Bombay High Court ultimately rejected the prayer for interim relief, finding no compelling reason to grant protection based solely on apprehension.
M/s.Varsha Productions v.Shivaji Rao Gaikwad
The appeal arose from an interlocutory order concerning a suit filed by the respondent, Shivaji Rao Gaikwad (Rajinikanth), seeking to restrain M/s.Varsha Productions from using his name, image, or style in their film project 'Main Hoon Rajinikanth'. The parties subsequently reached a settlement.
Ashim Ghosh v.The Controller Of Patents
The petitioner challenged the Controller's action of treating his patent application (No. 1350/DEL/2007) as 'Deemed to be Withdrawn'. The withdrawal was based on the assumption that the request for examination was not made within the prescribed period, despite the petitioner having filed Form-18 correctly and within the time limit. The court found that the clerical error in the covering letter did not invalidate the timely filing of the substantive examination request.
M/S Bilcare Limited v.M/S Associated Capsules Private Ltd.
The plaintiff filed a trademark suit (TM-75/2011) against the defendant. The defendant subsequently filed an application under Section 151 of the CPC seeking to recall previous orders, primarily to cross-examine the plaintiff's witness. The court dismissed this application, finding it devoid of merits and intended for dilatory tactics.
Merck Sharp And Dohme Corporation v.Glenmark Pharmaceuticals
Merck Sharp & Dohme Corporation appealed the dismissal of its application for an ad interim injunction against Glenmark Pharmaceuticals regarding the patented drug Sitagliptin. MSD alleged that Glenmark's products, marketed as Zita and Zitamet, infringed upon its patent (Indian Patent No. 209816), which covers a key molecule used to treat Type 2 Diabetes Mellitus. The Delhi High Court allowed the appeal, granting an interim injunction in favor of MSD, thereby restraining Glenmark from further selling or distributing the infringing products while the main suit proceeds.
Telefonaktiebolaget Lm Ericsson v.Intex Technologies (India) Limited
Telefonaktiebolaget Lm Ericsson filed a suit seeking permanent injunction and damages against Intex Technologies (India) Limited for infringing eight patents related to advanced telecommunication technologies, specifically AMR, 3G, and EDGE. The Delhi High Court addressed an interim application under Order XXXIX Rule 1 and 2 CPC. The court granted several stringent interim orders, including restraining the defendant from manufacturing or selling infringing devices and directing Customs authorities not to allow the import of such products.
Sarin Technologies Ltd v.Arvindbhai Lavjibhai Patel & 2
Sarin Technologies Ltd filed a suit against Arvindbhai Lavjibhai Patel and others concerning Patents Nos. 218301 and 221999. The defendants challenged the validity of these patents by filing a counter-claim for revocation. This order framed various issues, including novelty, inventorship, infringement, and entitlement to injunctions.
M/S Rspl Health Pvt. Ltd. v.Giani Ram Mittal & Ors.
The plaintiff filed a suit seeking permanent injunction against the defendants for alleged infringement of its trade mark XPERT and copyright, claiming prior adoption in respect of laundry products. The defendants countered by asserting their own established use of the 'SAGAR' trademark and arguing that the marks were dissimilar. The court ultimately dismissed the application for interim injunction, finding that the plaintiff failed to establish a prima facie case.
Societe Des Produits Nestle, .S.A. v.Sapan Kumar Bhatia & Ors
In this Delhi High Court case involving Nestle and Sapan Kumar Bhatia, the parties reached an amicable out-of-court settlement during the pendency of the litigation. The defendants acknowledged Nestle's ownership rights over the 'MAGGI' trademark, domain name (www.maggi.in), and copyright in the logo and label. Consequently, the court allowed a compromise application, decreeing the suit based on the agreed terms, which included a final payment of ₹2,00,000/- from the defendants to the plaintiffs.
Dr. Aloys Wobben v.Intellectual Property Appellate Board
Dr. Aloys Wobben challenged an order passed by the IPAB granting a plea of revocation made by private respondents. The dispute involved multiple patent infringement suits and corresponding revocation petitions/counter claims. The High Court addressed whether the Supreme Court's ruling on electing one remedy was affected by ongoing proceedings in the Delhi High Court.
Bayer CropScience AG v.The Assistant Controller of Patents and Designs, Government of India
Bayer CropScience AG appealed the Assistant Controller's order rejecting its patent application for long-chain inulin. The rejection was based on a lack of novelty and inventive step, arguing that the compound was merely isolated from artichoke roots. The High Court allowed the appeal, finding that the specific chain length and higher degree of polymerization achieved by fractionalizing the inulin constituted a novel invention with beneficial results.
Gilead Pharmasset, Llc v.Union Of India & Anr
Gilead Pharmasset challenged an order passed by the Patent Office, arguing that it violated natural justice because the decision considered grounds and material from pre-grant oppositions (filed under Section 25) without giving the petitioner a hearing. The court found that the availability of this opposition material created a potential for bias, leading to the setting aside of the impugned order.
Symed Labs Ltd. v.Glenmark Pharmaceuticals Ltd.
Symed Labs Ltd. filed a suit alleging that Glenmark Pharmaceuticals Ltd. was manufacturing and selling Linezolid using processes that infringed upon Symed's registered patents (IN '062 and IN '063). The Plaintiff argued that its patented methods were more economical, safer, and commercially viable than the prior art processes. The court granted an ad interim injunction restraining the Defendants from continuing the infringing activities.
Maharashtra Hybrid Seed Co. v.Union Of India And Anr
The petitioners challenged an order by the Registrar of PPVFR Authority which held that parent lines of known hybrid varieties could not be registered as 'new' plant varieties. The core issue was whether these parent lines retained novelty despite the commercial use and sale of resulting hybrid seeds.
Maharashtra Hybrid Seed Co. v.Union Of India And Anr
The petitioners challenged an order by the Registrar, PPV&FR Authority, which held that parent lines of known hybrid varieties could not be registered as 'new' plant varieties. The core issue was whether the development and sale of hybrid seeds from these parent lines invalidated the novelty claim for the original parental lines.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.